NextPharma Achieves Carbon Neutrality for Scope 1 and 2 Emissions

NextPharma has confirmed that it will achieve carbon neutrality for its Scope 1 and Scope 2 emissions starting January 1, 2025, marking a significant milestone in its sustainability journey.

Peter Burema, CEO of NextPharma, commented: “Here at NextPharma, we are deeply committed to the environmental sustainability agenda as well as health, safety, and social well-being matters, with the ultimate goal of enhancing the quality of life for everyone we serve. Through our culture of focused execution and continuous improvement, we have driven a sustained programme of capital investment and innovative technical solutions to deliver real results and material reduction in our CO2 emissions.”

NextPharma has implemented a range of initiatives to support its decarbonisation strategy, including investments in energy efficiency and renewable energy solutions. The company’s alignment with the Science Based Targets initiative (SBTi) further reinforces its commitment to ambitious emission reduction goals informed by climate science.

Reflecting on the company’s progress, Burema added, “I am pleased to [inform] that we are on track to achieve our goals in this area, and I am excited by the plans we have that enable us to deliver more as part of our next chapter.” Key focuses for the company, as stated by Burema, include a commitment to CO2 neutrality by January 2025, and strengthening the company’s commitment to sustainability and emission reduction by aligning targets and joining the SBTi initiatives.

This achievement underscores NextPharma’s dedication to environmental sustainability while demonstrating leadership in addressing global climate challenges.

Source:
NextPharma is now carbon neutral! [Accessed January 15, 2025] https://nextpharma.com/news-events/article-detail/nextpharma-is-now-carbon-neutral